A share price of Opko Health Inc [OPK] is currently trading at $1.28, up 0.79%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The OPK shares have lost -3.76% over the last week, with a monthly amount drifted -16.34%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Opko Health Inc [NASDAQ: OPK] stock has seen the most recent analyst activity on October 31, 2025, when Jefferies downgraded its rating to a Hold but kept the price target unchanged to $1.60 for it. On June 29, 2023, upgrade upgraded it’s rating to Outperform but maintained its price target of $2 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $3 on December 15, 2022. Barrington Research downgraded its rating to a Mkt Perform. Ladenburg Thalmann started tracking with a Buy rating for this stock on June 21, 2021, and assigned it a price target of $7. In a note dated November 25, 2019, Piper Jaffray initiated an Overweight rating and provided a target price of $2.50 on this stock.
Opko Health Inc experienced fluctuations in its stock price throughout the past year between $1.11 and $2.04. Currently, Wall Street analysts expect the stock to reach $1.6 within the next 12 months. Opko Health Inc [NASDAQ: OPK] shares were valued at $1.28 at the most recent close of the market. An investor can expect a potential return of 25.0% based on the average OPK price forecast.
Analyzing the OPK fundamentals
Trailing Twelve Months sales for Opko Health Inc [NASDAQ:OPK] were 642.03M which represents -12.65% decline. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -0.17%, Pretax Profit Margin comes in at -0.25%, and Net Profit Margin reading is -0.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.11 and Total Capital is -0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2500 points at the first support level, and at 1.2200 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3000, and for the 2nd resistance point, it is at 1.3200.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Opko Health Inc [NASDAQ:OPK] is 3.70. As well, the Quick Ratio is 3.32, while the Cash Ratio is 2.45. Considering the valuation of this stock, the price to sales ratio is 1.53, the price to book ratio is 0.75.
Transactions by insiders
Recent insider trading involved FROST PHILLIP MD ET AL, CEO & Chairman, that happened on Nov 18 ’25 when 0.53 million shares were purchased. CEO & Chairman, FROST PHILLIP MD ET AL completed a deal on Oct 31 ’25 to buy 0.15 million shares. Meanwhile, CEO & Chairman FROST PHILLIP MD ET AL bought 0.68 million shares on Aug 08 ’25.
